FindTrial
Sign In

A Platform for Rapid Immuno-detection and Emergency Vaccine Development of Novel Coronavirus (2019-COV)

A Platform for Rapid Immuno-detection and Emergency Vaccine Development of Coronavirus SARS-CoV-2

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030934
Enrollment
Unknown
Registered
2020-03-18
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel coronavirus pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

The Fifth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. novel coronavirus pneumonia confirmed patients, and clinical classification is common, heavy or severe; 2. Willing to participate in rapid immunoassay research.

Exclusion criteria

Exclusion criteria: Exclusion criteria (subjects cannot enter the study if they meet any of the following conditions): (1) There was no rapid immunoassay; (2) Subjects who could not cooperate with information collection were excluded.

Design outcomes

Primary

MeasureTime frame
Immune response multiomics;—

Countries

China

Contacts

Public ContactTian Lin

The Fifth Affiliated Hospital of Sun Yat-sen University

tianlin@mail.sysu.edu.cn+86 0756 2528222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026